Differential stress transcriptome landscape of historic and recently emerged hypervirulent strains of Clostridium difficile strains determined using RNA-seq

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Scaria, Joy ^a   Mao, Chunhong ^b   Chen, Jenn Wei ^a   McDonough, Sean P ^a   Sobral, Bruno ^b   Chang, Yung Fu ^a  

^a Department of Molecular Biology and Genetics   (United States)

^b VIRGINIA BIOINFORMATICS INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; SMALL REGULATORY RNA; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; CORE GENE; ENVIRONMENTAL STRESS; GENE EXPRESSION; GENETIC TRANSCRIPTION; METABOLIC STRESS; MICROBIAL METABOLISM; NONHUMAN; OSMOTIC STRESS; RNA SEQUENCE; TRANSCRIPTOMICS;

CLOSTRIDIUM DIFFICILE; COMMUNICABLE DISEASES, EMERGING; ENTEROCOLITIS, PSEUDOMEMBRANOUS; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; OSMOTIC PRESSURE; RNA, BACTERIAL; SPECIES SPECIFICITY; TRANSCRIPTOME;

EID: 84892393570     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078489     Document Type: Article

References (67)

1. Rupnik M, Wilcox MH, Gerding DN (2009) Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 7: 526-536. doi:10.1038/nrmicro2164. PubMed: 19528959.
2. Gerding DN (2012) Clostridium difficile infection prevention: biotherapeutics, immunologics, and vaccines. Discov Med 13: 75-83. PubMed: 22284786.
3. Loo VG, Bourgault AM, Poirier L, Lamothe F, Michaud S et al. (2011) Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 365: 1693-1703. doi:10.1056/NEJMoa1012413. PubMed: 22047560.
4. Pacheco SM, Johnson S (2013) Important clinical advances in the understanding of Clostridium difficile infection. Curr Opin Gastroenterol 29: 42-48. doi:10.1097/MOG.0b013e32835a68d4. PubMed: 23207596.
5. Norén T (2010) Clostridium difficile and the disease it causes. Methods Mol Biol 646: 9-35. doi:10.1007/978-1-60327-365-7-2. PubMed: 20597000.
6. Lyerly DM, Krivan HC, Wilkins TD (1988) Clostridium difficile: its disease and toxins. Clin Microbiol Rev 1: 1-18. PubMed: 3144429.
7. Rupnik M, Dupuy B, Fairweather NF, Gerding DN, Johnson S et al. (2005) (2005) Revised nomenclature of Clostridium difficile toxins and associated genes. J Med Microbiol 54: 113-117. doi:10.1099/jmm.0.45810-0. PubMed: 15673503.
8. Chitnis AS, Holzbauer SM, Belflower RM, Winston LG, Bamberg WM et al. (2013) Epidemiology of Community-Associated Clostridium difficile Infection, 2009 Through 2011. JAMA. Intern Med 173: 1359-1367.
9. Gerding DN (2010) Global epidemiology of Clostridium difficile infection in 2010. Infect Control Hosp Epidemiol 31 Suppl 1: S32-S34. doi: 10.1086/655998. PubMed: 20929364.
10. Jones AM, Kuijper EJ, Wilcox MH (2013) Clostridium difficile: a European perspective. J Infect 66: 115-128. doi:10.1016/j.jinf.2012.10.019. PubMed: 23103666.
11. McDonald LC, Killgore GE, Thompson A, Owens RC Jr., Kazakova SV et al. (2005) An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 353: 2433-2441. doi:10.1056/NEJMoa051590. PubMed: 16322603.
12. He M, Miyajima F, Roberts P, Ellison L, Pickard DJ et al. (2013) Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Genet 45: 109-113. PubMed: 23222960.
13. Warny M, Pepin J, Fang A, Killgore G, Thompson A et al. (2005) Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366: 1079-1084. doi:10.1016/S0140-6736(05)67420-X. PubMed: 16182895.
14. Khanna S, Pardi DS, Aronson SL, Kammer PP, Orenstein R et al. (2012) The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol 107: 89-95. doi:10.1038/ajg.2011.398. PubMed: 22108454.
15. Songer JG, Anderson MA (2006) Clostridium difficile: an important pathogen of food animals. Anaerobe 12: 1-4. doi:10.1016/j.anaerobe.2005.09.001. PubMed: 16701605.
16. Gould LH, Limbago B (2010) Clostridium difficile in food and domestic animals: a new foodborne pathogen? Clin Infect Dis Off Publ Infect Dis Soc Am 51: 577-582. doi:10.1086/655692. PubMed: 20642351.
17. Sebaihia M, Wren BW, Mullany P, Fairweather NF, Minton N et al. (2006) The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat Genet 38: 779-786. doi:10.1038/ng1830. PubMed: 16804543.
18. Stabler RA, Gerding DN, Songer JG, Drudy D, Brazier JS et al. (2006) Comparative Phylogenomics of Clostridium difficile Reveals Clade Specificity and Microevolution of Hypervirulent Strains. J Bacteriol 188: 7297-7305. doi:10.1128/JB.00664-06. PubMed: 17015669.
19. Janvilisri T, Scaria J, Thompson AD, Nicholson A, Limbago BM et al. (2009) Microarray identification of Clostridium difficile core components and divergent regions associated with host origin. J Bacteriol 191: 3881-3891. doi:10.1128/JB.00222-09. PubMed: 19376880.
20. Scaria J, Ponnala L, Janvilisri T, Yan W, Mueller LA et al. (2010) Analysis of ultra low genome conservation in Clostridium difficile. PLOS ONE 5: e15147. doi:10.1371/journal.pone.0015147. PubMed: 21170335.
21. Emerson JE, Stabler RA, Wren BW, Fairweather NF (2008) Microarray analysis of the transcriptional responses of Clostridium difficile to environmental and antibiotic stress. J Med Microbiol 57: 757-764. doi: 10.1099/jmm.0.47657-0. PubMed: 18480334.
22. Janvilisri T, Scaria J, Chang YF (2010) Transcriptional profiling of Clostridium difficile and Caco-2 cells during infection. J Infect Dis 202: 282-290. doi:10.1086/653484. PubMed: 20521945.
23. Scaria J, Janvilisri T, Fubini S, Gleed RD, McDonough SP et al. (2011) Clostridium difficile transcriptome analysis using pig ligated loop model reveals modulation of pathways not modulated in vitro. J Infect Dis 203: 1613-1620. doi:10.1093/infdis/jir112. PubMed: 21592991.
24. Ternan NG, Jain S, Srivastava M, McMullan G (2012) Comparative transcriptional analysis of clinically relevant heat stress response in Clostridium difficile strain 630. PLOS ONE 7: e42410. doi:10.1371/journal.pone. 0042410. PubMed: 22860125.
25. Stabler RA, He M, Dawson L, Martin M, Valiente E et al. (2009) Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol 10: R102. doi:10.1186/gb-2009-10-9-r102. PubMed: 19781061.
26. He M, Sebaihia M, Lawley TD, Stabler RA, Dawson LF et al. (2010) Evolutionary dynamics of Clostridium difficile over short and long time scales. Proc Natl Acad Sci U S A 107: 7527-7532. doi:10.1073/pnas.0914322107. PubMed: 20368420.
27. Forgetta V, Oughton MT, Marquis P, Brukner I, Blanchette R et al. (2011) Fourteen-genome comparison identifies DNA markers for severe-disease-associated strains of Clostridium difficile. J Clin Microbiol 49: 2230-2238. doi:10.1128/JCM.00391-11. PubMed: 21508155.
28. Karasawa T, Ikoma S, Yamakawa K, Nakamura S (1995) A defined growth medium for Clostridium difficile. Microbiology 141 (2): 371-375. doi:10.1099/13500872-141-2-371.
29. Karlsson S, Burman LG, Akerlund T (2008) Induction of toxins in Clostridium difficile is associated with dramatic changes of its metabolism. Microbiology 154: 3430-3436. doi:10.1099/mic.0.2008/019778-0. PubMed: 18957596.
30. Antunes A, Martin-Verstraete I, Dupuy B (2011) CcpA-mediated repression of Clostridium difficile toxin gene expression. Mol Microbiol 79: 882-899. doi:10.1111/j.1365-2958.2010.07495.x. PubMed: 21299645.
31. Waligora AJ, Barc MC, Bourlioux P, Collignon A, Karjalainen T (1999) Clostridium difficile cell attachment is modified by environmental factors. Appl Environ Microbiol 65: 4234-4238. PubMed: 10473442.
32. Hennequin C, Porcheray F, Waligora-Dupriet A, Collignon A, Barc M et al. (2001) GroEL (Hsp60) of Clostridium difficile is involved in cell adherence. Microbiology 147: 87-96. PubMed: 11160803.
33. Corfield AP, Myerscough N, Longman R, Sylvester P, Arul S et al. (2000) Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease. Gut 47: 589-594. doi:10.1136/gut.47.4.589. PubMed: 10986224.
34. Langmead B, Trapnell C, Pop M, Salzberg SL (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10: R25. doi:10.1186/gb-2009-10-3-r25. PubMed: 19261174.
35. Roberts A, Pimentel H, Trapnell C, Pachter L (2011) Identification of novel transcripts in annotated genomes using RNA-Seq. Bioinformatics 27: 2325-2329. doi:10.1093/bioinformatics/btr355. PubMed: 21697122.
36. Trapnell C, Hendrickson DG, Sauvageau M, Goff L, Rinn JL et al. (2013) Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat Biotechnol 31: 46-53. PubMed: 23222703.
37. Burge SW, Daub J, Eberhardt R, Tate J, Barquist L et al. (2013) Rfam 11.0: 10 years of RNA families. Nucleic Acids Res 41: D226-232.
38. Li L, Stoeckert CJ Jr., Roos DS (2003) OrthoMCL: identification of ortholog groups for eukaryotic genomes. Genome Res 13: 2178-2189. doi:10.1101/gr.1224503. PubMed: 12952885.
39. Karp PD, Paley S, Romero P (2002) The Pathway Tools software. Bioinformatics 18 Suppl 1: S225-S232. doi:10.1093/bioinformatics/18.suppl-1. S225. PubMed: 12169551.
40. Paley SM, Karp PD (2006) The Pathway Tools cellular overview diagram and Omics Viewer. Nucleic Acids Res 34: 3771-3778. doi: 10.1093/nar/gkl334. PubMed: 16893960.
41. Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A et al. (2011) The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 39: D561-D568. doi:10.1093/nar/gkq973. PubMed: 21045058.
42. Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T (2011) Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 27: 431-432. doi:10.1093/bioinformatics/btq675. PubMed: 21149340.
43. Chen JW, Scaria J, Mao C, Sobral B, Zhang S et al. (2013) Proteomic Comparison of Historic and Recently Emerged Hypervirulent Clostridium difficile Strains. J Proteome Res 12: 1151-1161. doi: 10.1021/pr3007528. PubMed: 23298230.
44. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G et al. (2010) Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 28: 511-515. doi:10.1038/nbt.1621. PubMed: 20436464.
45. Gillespie JJ, Wattam AR, Cammer SA, Gabbard JL, Shukla MP et al. (2011) PATRIC: the comprehensive bacterial bioinformatics resource with a focus on human pathogenic species. Infect Immun 79: 4286-4298. doi:10.1128/IAI.00207-11. PubMed: 21896772.
46. Tettelin H, Masignani V, Cieslewicz MJ, Donati C, Medini D et al. (2005) Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome". Proc Natl Acad Sci U S A 102: 13950-13955. doi:10.1073/pnas.0506758102. PubMed: 16172379.
47. Tettelin H, Riley D, Cattuto C, Medini D (2008) Comparative genomics: the bacterial pan-genome. Curr Opin Microbiol 11: 472-477. doi: 10.1016/j.mib.2008.09.006. PubMed: 19086349.
48. Stabler RA, Dawson LF, Phua LT, Wren BW (2008) Comparative analysis of BI/NAP1/027 hypervirulent strains reveals novel toxin Bencoding gene (tcdB) sequences. J Med Microbiol 57: 771-775. doi: 10.1099/jmm.0.47743-0. PubMed: 18480336.
49. Karlsson S, Lindberg A, Norin E, Burman LG, Akerlund T (2000) Toxins, butyric acid, and other short-chain fatty acids are coordinately expressed and down-regulated by cysteine in Clostridium difficile. Infect Immun 68: 5881-5888. doi:10.1128/IAI.68.10.5881-5888.2000. PubMed: 10992498.
50. Waligora AJ, Hennequin C, Mullany P, Bourlioux P, Collignon A et al. (2001) Characterization of a cell surface protein of Clostridium difficile with adhesive properties. Infect Immun 69: 2144-2153. doi:10.1128/IAI.69.4.2144-2153. 2001. PubMed: 11254569.
51. Wang Z, Gerstein M, Snyder M (2009) RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 10: 57-63. doi:10.1038/nrg2484. PubMed: 19015660.
52. Yamakawa K, Kamiya S, Meng XQ, Karasawa T, Nakamura S (1994) Toxin production by Clostridium difficile in a defined medium with limited amino acids. J Med Microbiol 41: 319-323. doi: 10.1099/00222615-41-5-319. PubMed: 7966203.
53. Karasawa T, Maegawa T, Nojiri T, Yamakawa K, Nakamura S (1997) Effect of arginine on toxin production by Clostridium difficile in defined medium. Microbiol Immunol 41: 581-585. PubMed: 9310936.
54. Ikeda D, Karasawa T, Yamakawa K, Tanaka R, Namiki M et al. (1998) Effect of isoleucine on toxin production by Clostridium difficile in a defined medium. Zentralbl Bakteriol Int J Med Microbiol 287: 375-386. doi:10.1016/S0934-8840(98) 80174-6.
55. Yamakawa K, Karasawa T, Ohta T, Hayashi H, Nakamura S (1998) Inhibition of enhanced toxin production by Clostridium difficile in biotinlimited conditions. J Med Microbiol 47: 767-771. doi: 10.1099/00222615-47-9-767. PubMed: 9736158.
56. Maegawa T, Karasawa T, Ohta T, Wang X, Kato H et al. (2002) Linkage between toxin production and purine biosynthesis in Clostridium difficile. J Med Microbiol 51: 34-41. PubMed: 11800470.
57. Lei XH, Bochner BR (2013) Using phenotype microarrays to determine culture conditions that induce or repress toxin production by Clostridium difficile and other microorganisms. PLOS ONE 8: e56545. doi:10.1371/journal. pone.0056545. PubMed: 23437164.
58. Spigaglia P, Mastrantonio P (2002) Molecular Analysis of the Pathogenicity Locus and Polymorphism in the Putative Negative Regulator of Toxin Production (TcdC) among Clostridium difficile Clinical Isolates. J Clin Microbiol 40: 3470-3475. doi:10.1128/JCM.40.9.3470-3475.2002. PubMed: 12202595.
59. Hennequin C, Collignon A, Karjalainen T (2001) Analysis of expression of GroEL (Hsp60) of Clostridium difficile in response to stress. Microb Pathog 31: 255-260. doi:10.1006/mpat.2001.0468. PubMed: 11710845.
60. Stock JB, Waygood EB, Meadow ND, Postma PW, Roseman S (1982) Sugar transport by the bacterial phosphotransferase system. The glucose receptors of the Salmonella typhimurium phosphotransferase system. J Biol Chem 257: 14543-14552. PubMed: 6292227.
61. Dupuy B, Sonenshein AL (1998) Regulated transcription of Clostridium difficile toxin genes. Mol Microbiol 27: 107-120. doi:10.1046/j.1365-2958.1998. 00663.x. PubMed: 9466260.
62. Peterkofsky A, Wang G, Seok YJ (2006) Parallel PTS systems. Arch Biochem Biophys 453: 101-107. doi:10.1016/j.abb.2006.01.004. PubMed: 17022110.
63. Garsin DA (2010) Ethanolamine utilization in bacterial pathogens: roles and regulation. Nat Rev Microbiol 8: 290-295. doi:10.1038/nrmicro2334. PubMed: 20234377.
64. Roof DM, Roth JR (1988) Ethanolamine utilization in Salmonella typhimurium. J Bacteriol 170: 3855-3863. PubMed: 3045078.
65. Scardoni G, Petterlini M, Laudanna C (2009) Analyzing biological network parameters with CentiScaPe. Bioinformatics 25: 2857-2859. doi:10.1093/ bioinformatics/btp517. PubMed: 19729372.
66. Burns DA, Heap JT, Minton NP (2010) The diverse sporulation characteristics of Clostridium difficile clinical isolates are not associated with type. Anaerobe 16: 618-622. doi:10.1016/j.anaerobe.2010.10.001. PubMed: 20950700.
67. Soutourina OA, Monot M, Boudry P, Saujet L, Pichon C et al. (2013) Genome-Wide Identification of Regulatory RNAs in the Human Pathogen Clostridium difficile. PLOS Genet 9: e1003493. PubMed: 23675309.